Abstraction Health

Fish Oil / Omega-3 — Stack & Timing

Educational timing and stacking information based on how Fish Oil / Omega-3 has been studied. Not a prescription. Not medical advice.

This is educational information only. Consult a healthcare provider before starting any supplement.

Stack & Timing Guidance

Educational summary based on how Fish Oil / Omega-3 has been studied and commonly used.

🟢Strong Evidence

Commonly studied timing

With food

Fish oil should be taken with meals to improve absorption of fat-soluble omega-3s and reduce gastrointestinal side effects such as fishy burps and nausea. No strong evidence favors morning over evening timing specifically.

Dose ranges used in studies

10004000 mg

Expert claims (Huberman) suggest 2–4g/day total omega-3s for triglyceride lowering, with 2–3g EPA specifically for mood and cognitive benefits. Meta-analyses cited suggest >1g EPA for anti-inflammatory and mood effects. The studies in this set cover conditions including depression, PCOS, migraine, Alzheimer's, multiple sclerosis, and arterial stiffness, generally using doses in the 1–4g range. No raw N or specific findings were provided for individual studies, so dose range is inferred from expert claims and general literature norms.

↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.

Commonly paired with

Vitamin D3

Synergistic anti-inflammatory effects; both are fat-soluble and often co-deficient in populations with metabolic or mood disorders

Magnesium

Complementary benefit for migraine prevention and mood regulation alongside omega-3s

Vitamin E

Antioxidant protection against lipid peroxidation of omega-3s; one RCT in dataset combined carotenoids, omega-3s, and vitamin E for Alzheimer's symptoms

Carotenoids (e.g., Lutein, Astaxanthin)

Combined with omega-3s and vitamin E in Alzheimer's RCT; antioxidant synergy may protect neural tissue

Rosuvastatin (low-dose)

One RCT in dataset compared fish oil alongside statins for lipid and inflammatory biomarker management

Safety & interactions

Fish oil is generally well tolerated. Common side effects include fishy aftertaste, GI upset, and loose stools at higher doses. One RCT in this dataset specifically examined perioperative bleeding risk — fish oil may modestly increase bleeding time at higher doses (>3g/day), though evidence for clinically significant bleeding is mixed. Oxidation of omega-3s in low-quality supplements is a concern; refrigeration and products with added vitamin E are preferred. Long-term high-dose use (>5g/day) should be medically supervised.

Known interactions
  • Anticoagulants (e.g., warfarin, heparin) — may potentiate antiplatelet/anticoagulant effects and increase bleeding risk
  • Antiplatelet drugs (e.g., aspirin, clopidogrel) — additive effect on platelet aggregation inhibition
  • Blood pressure medications — omega-3s have mild antihypertensive effects; may augment hypotensive drugs
  • Orlistat — may reduce absorption of fat-soluble omega-3s
  • Vitamin E (high dose) — both have antiplatelet properties; combined high doses may increase bleeding risk
Contraindications

Use with caution or avoid at therapeutic doses (>3g/day) in individuals scheduled for surgery (perioperative bleeding risk per RCT in dataset), those on anticoagulant therapy without medical supervision, or individuals with fish/shellfish allergies (use algae-based omega-3s as alternative). Not contraindicated in pregnancy at standard doses; high-dose supplementation in pregnancy should be physician-guided.

Evidence basis: Evidence drawn from 10 studies including 6 RCTs and 4 systematic reviews/meta-analyses covering triglyceride reduction, depression, PCOS, multiple sclerosis, Alzheimer's disease, migraine, arterial stiffness, dysmenorrhea, and perioperative bleeding. Quality ratings ranged from moderate to strong. Note: individual study findings and sample sizes were not provided in the source data, limiting specificity. Expert dose claims from Andrew Huberman were used to supplement dose range estimates. Overall evidence base for omega-3 supplementation across cardiometabolic and neurological outcomes is well-established in broader literature.